The pre-paid solar company has now raised $23m in total this year after securing a second investment from solar installer SolarCity.

The networking technology company has added Mitsui to a series B round that reached a $12.5m first close in October.

Pharmstandard has participated in a series B round for the biopharmaceutical company, which focuses on metabolic and orphan diseases.

Queensland life sciences spin-out Protagonist Therapeutics closes second tranche of $18m series B round.

Marketing firm Blue Focus Communcations has co-led the $8.8m first tranche of a planned $11.6m round for predictive analytics company Blab.

Fenqile, which provides its Chinese users with payment plans for electronic goods, raised the money only three months after a $10m series A round.